Amgen has made a play in a hot area of immunology R&D, paying $400 million upfront to claim rights to an OX40-targeting drug from Kyowa Kirin that is ready for phase 3 testing for atopic ...

In the treatment of psoriasis, preliminary evidence supports the hypothesis that IL-23 inhibitors are capable of extended ...

German pharma Grünenthal has started the process of taking ownership of 13 ageing medicines developed by Japan's Kyowa Kirin, which are currently sold by affiliate companies across Europe. The ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The therapeutic landscape for diabetic macular edema ...

A novel approach using native mass spectrometry has significantly advanced the understanding of stabilization mechanisms of ...

Existing research indicates that the accuracy of a Parkinson’s disease diagnosis hovers between 55% and 78% in the first five years of assessment. That’s partly because Parkinson’s sibling movement ...

Great Place to Work® – a renowned global research, training, and consultancy firm – unveiled the top 20 Best Workplaces in ...

2269.T Meiji Holdings Co., Ltd.

Frontier declined to share what percentage of its workforce would be impacted. Story Feb. 4 - Kyowa Kirin: The Japanese pharma is letting go of 52 employees in Princeton, New Jersey. The location ...